Professor Trevor Jones CBE appointed chairman of Simbec Research
pharmafile | July 24, 2013 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing | ABPI, simbec, trevor jones
Clinical research organisation Simbec Research has appointed Professor Trevor Jones CBE as non-executive chairman of the Board of directors.
Jones was formerly Group R&D director of Wellcome and director general of the Association of the British Pharmaceutical Industry (ABPI).
Jones joins the Board following the recent acquisition of the company through investment from the Wales Life Sciences Investment Fund (WLSIF), along with Professor Sir Chris Evans and Simbec’s executive directors Howard Jenkins and Dr Trevor Tanner.
Evans, from Arthurian and chairman of the Welsh Life Sciences Hub said: “We are delighted that Professor Trevor Jones has agreed to be the new chairman of Simbec Research. Professor Jones brings to the Board his wide, international understanding of pharmaceutical and biotech R&D, proven leadership skills and we are confident that Simbec can continue to grow.”
Jones is well known internationally for his activities in clinical research and drug discovery and development in the pharma industry. He has served on many committees including the UK Government Medicines Commission, chair of the UK Genetics Advisory Board, the Council of King’s College London and as a Commissioner at The World Health Organisation (WHO).
He is a member of several Boards of Pharmaceutical companies in Europe and the US and has received honorary Doctorates/Gold medals from six universities.
Jones said: “It is a great pleasure to be joining Simbec with its established reputation for excellence in the efficient conduct of clinical trials for regulatory approvals. The clinical studies that Simbec performs are a pivotal component of the success of the pharmaceutical and biotech industry and we are well placed for future growth.”
Related Content
The November 2020 issue of Pharmafocus is available to read free online now!
The latest monthly edition of Pharmafocus is available to read for free online now!
UK life sciences industry does not want no-deal Brexit, says ABPI Chief
Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a …
ABPI Chief Executive Mike Thompson to retire by the end of 2019
The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike …
